table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Anti-Infective Vaccines Market Size Analysis from 2022 to 2027
1.5.1 Global Anti-Infective Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Anti-Infective Vaccines Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Anti-Infective Vaccines Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Anti-Infective Vaccines Industry Impact
Chapter 2 Global Anti-Infective Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Anti-Infective Vaccines (Volume and Value) by Type
2.1.1 Global Anti-Infective Vaccines Consumption and Market Share by Type (2016-2021)
2.1.2 Global Anti-Infective Vaccines Revenue and Market Share by Type (2016-2021)
2.2 Global Anti-Infective Vaccines (Volume and Value) by Application
2.2.1 Global Anti-Infective Vaccines Consumption and Market Share by Application (2016-2021)
2.2.2 Global Anti-Infective Vaccines Revenue and Market Share by Application (2016-2021)
2.3 Global Anti-Infective Vaccines (Volume and Value) by Regions
2.3.1 Global Anti-Infective Vaccines Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Anti-Infective Vaccines Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Anti-Infective Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Anti-Infective Vaccines Consumption by Regions (2016-2021)
4.2 North America Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
4.10 South America Anti-Infective Vaccines Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Anti-Infective Vaccines Market Analysis
5.1 North America Anti-Infective Vaccines Consumption and Value Analysis
5.1.1 North America Anti-Infective Vaccines Market Under COVID-19
5.2 North America Anti-Infective Vaccines Consumption Volume by Types
5.3 North America Anti-Infective Vaccines Consumption Structure by Application
5.4 North America Anti-Infective Vaccines Consumption by Top Countries
5.4.1 United States Anti-Infective Vaccines Consumption Volume from 2016 to 2021
5.4.2 Canada Anti-Infective Vaccines Consumption Volume from 2016 to 2021
5.4.3 Mexico Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 6 East Asia Anti-Infective Vaccines Market Analysis
6.1 East Asia Anti-Infective Vaccines Consumption and Value Analysis
6.1.1 East Asia Anti-Infective Vaccines Market Under COVID-19
6.2 East Asia Anti-Infective Vaccines Consumption Volume by Types
6.3 East Asia Anti-Infective Vaccines Consumption Structure by Application
6.4 East Asia Anti-Infective Vaccines Consumption by Top Countries
6.4.1 China Anti-Infective Vaccines Consumption Volume from 2016 to 2021
6.4.2 Japan Anti-Infective Vaccines Consumption Volume from 2016 to 2021
6.4.3 South Korea Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 7 Europe Anti-Infective Vaccines Market Analysis
7.1 Europe Anti-Infective Vaccines Consumption and Value Analysis
7.1.1 Europe Anti-Infective Vaccines Market Under COVID-19
7.2 Europe Anti-Infective Vaccines Consumption Volume by Types
7.3 Europe Anti-Infective Vaccines Consumption Structure by Application
7.4 Europe Anti-Infective Vaccines Consumption by Top Countries
7.4.1 Germany Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.2 UK Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.3 France Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.4 Italy Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.5 Russia Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.6 Spain Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.7 Netherlands Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.8 Switzerland Anti-Infective Vaccines Consumption Volume from 2016 to 2021
7.4.9 Poland Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 8 South Asia Anti-Infective Vaccines Market Analysis
8.1 South Asia Anti-Infective Vaccines Consumption and Value Analysis
8.1.1 South Asia Anti-Infective Vaccines Market Under COVID-19
8.2 South Asia Anti-Infective Vaccines Consumption Volume by Types
8.3 South Asia Anti-Infective Vaccines Consumption Structure by Application
8.4 South Asia Anti-Infective Vaccines Consumption by Top Countries
8.4.1 India Anti-Infective Vaccines Consumption Volume from 2016 to 2021
8.4.2 Pakistan Anti-Infective Vaccines Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Anti-Infective Vaccines Market Analysis
9.1 Southeast Asia Anti-Infective Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Anti-Infective Vaccines Market Under COVID-19
9.2 Southeast Asia Anti-Infective Vaccines Consumption Volume by Types
9.3 Southeast Asia Anti-Infective Vaccines Consumption Structure by Application
9.4 Southeast Asia Anti-Infective Vaccines Consumption by Top Countries
9.4.1 Indonesia Anti-Infective Vaccines Consumption Volume from 2016 to 2021
9.4.2 Thailand Anti-Infective Vaccines Consumption Volume from 2016 to 2021
9.4.3 Singapore Anti-Infective Vaccines Consumption Volume from 2016 to 2021
9.4.4 Malaysia Anti-Infective Vaccines Consumption Volume from 2016 to 2021
9.4.5 Philippines Anti-Infective Vaccines Consumption Volume from 2016 to 2021
9.4.6 Vietnam Anti-Infective Vaccines Consumption Volume from 2016 to 2021
9.4.7 Myanmar Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 10 Middle East Anti-Infective Vaccines Market Analysis
10.1 Middle East Anti-Infective Vaccines Consumption and Value Analysis
10.1.1 Middle East Anti-Infective Vaccines Market Under COVID-19
10.2 Middle East Anti-Infective Vaccines Consumption Volume by Types
10.3 Middle East Anti-Infective Vaccines Consumption Structure by Application
10.4 Middle East Anti-Infective Vaccines Consumption by Top Countries
10.4.1 Turkey Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.3 Iran Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.5 Israel Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.6 Iraq Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.7 Qatar Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.8 Kuwait Anti-Infective Vaccines Consumption Volume from 2016 to 2021
10.4.9 Oman Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 11 Africa Anti-Infective Vaccines Market Analysis
11.1 Africa Anti-Infective Vaccines Consumption and Value Analysis
11.1.1 Africa Anti-Infective Vaccines Market Under COVID-19
11.2 Africa Anti-Infective Vaccines Consumption Volume by Types
11.3 Africa Anti-Infective Vaccines Consumption Structure by Application
11.4 Africa Anti-Infective Vaccines Consumption by Top Countries
11.4.1 Nigeria Anti-Infective Vaccines Consumption Volume from 2016 to 2021
11.4.2 South Africa Anti-Infective Vaccines Consumption Volume from 2016 to 2021
11.4.3 Egypt Anti-Infective Vaccines Consumption Volume from 2016 to 2021
11.4.4 Algeria Anti-Infective Vaccines Consumption Volume from 2016 to 2021
11.4.5 Morocco Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 12 Oceania Anti-Infective Vaccines Market Analysis
12.1 Oceania Anti-Infective Vaccines Consumption and Value Analysis
12.2 Oceania Anti-Infective Vaccines Consumption Volume by Types
12.3 Oceania Anti-Infective Vaccines Consumption Structure by Application
12.4 Oceania Anti-Infective Vaccines Consumption by Top Countries
12.4.1 Australia Anti-Infective Vaccines Consumption Volume from 2016 to 2021
12.4.2 New Zealand Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 13 South America Anti-Infective Vaccines Market Analysis
13.1 South America Anti-Infective Vaccines Consumption and Value Analysis
13.1.1 South America Anti-Infective Vaccines Market Under COVID-19
13.2 South America Anti-Infective Vaccines Consumption Volume by Types
13.3 South America Anti-Infective Vaccines Consumption Structure by Application
13.4 South America Anti-Infective Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.2 Argentina Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.3 Columbia Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.4 Chile Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.5 Venezuela Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.6 Peru Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Anti-Infective Vaccines Consumption Volume from 2016 to 2021
13.4.8 Ecuador Anti-Infective Vaccines Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Anti-Infective Vaccines Business
14.1 Emergent BioDefense Operations Lansing Inc.
14.1.1 Emergent BioDefense Operations Lansing Inc. Company Profile
14.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Specification
14.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Sanofi Pasteur
14.2.1 Sanofi Pasteur Company Profile
14.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Specification
14.2.3 Sanofi Pasteur Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Merck & Co.
14.3.1 Merck & Co. Company Profile
14.3.2 Merck & Co. Anti-Infective Vaccines Product Specification
14.3.3 Merck & Co. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 MedImmune LLC
14.4.1 MedImmune LLC Company Profile
14.4.2 MedImmune LLC Anti-Infective Vaccines Product Specification
14.4.3 MedImmune LLC Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Novartis Vaccines
14.5.1 Novartis Vaccines Company Profile
14.5.2 Novartis Vaccines Anti-Infective Vaccines Product Specification
14.5.3 Novartis Vaccines Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Diagnostics Ltd.
14.6.1 Diagnostics Ltd. Company Profile
14.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Specification
14.6.3 Diagnostics Ltd. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Intercell Biomedical
14.7.1 Intercell Biomedical Company Profile
14.7.2 Intercell Biomedical Anti-Infective Vaccines Product Specification
14.7.3 Intercell Biomedical Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 MassBiologics
14.8.1 MassBiologics Company Profile
14.8.2 MassBiologics Anti-Infective Vaccines Product Specification
14.8.3 MassBiologics Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Barr Labs, Inc.
14.9.1 Barr Labs, Inc. Company Profile
14.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Specification
14.9.3 Barr Labs, Inc. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Organon Teknika Co.
14.10.1 Organon Teknika Co. Company Profile
14.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Specification
14.10.3 Organon Teknika Co. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 GlaxoSmithKline Biologicals
14.11.1 GlaxoSmithKline Biologicals Company Profile
14.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Specification
14.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 CSL Ltd.
14.12.1 CSL Ltd. Company Profile
14.12.2 CSL Ltd. Anti-Infective Vaccines Product Specification
14.12.3 CSL Ltd. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 ID Biomedical Co.
14.13.1 ID Biomedical Co. Company Profile
14.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Specification
14.13.3 ID Biomedical Co. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Protein Sciences Co.
14.14.1 Protein Sciences Co. Company Profile
14.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Specification
14.14.3 Protein Sciences Co. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Wyeth Pharmaceuticals, Inc.
14.15.1 Wyeth Pharmaceuticals, Inc. Company Profile
14.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Specification
14.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Berna Biotech
14.16.1 Berna Biotech Company Profile
14.16.2 Berna Biotech Anti-Infective Vaccines Product Specification
14.16.3 Berna Biotech Anti-Infective Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Anti-Infective Vaccines Market Forecast (2022-2027)
15.1 Global Anti-Infective Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Anti-Infective Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Anti-Infective Vaccines Value and Growth Rate Forecast (2022-2027)
15.2 Global Anti-Infective Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Anti-Infective Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Anti-Infective Vaccines Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Anti-Infective Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Anti-Infective Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Anti-Infective Vaccines Consumption Forecast by Type (2022-2027)
15.3.2 Global Anti-Infective Vaccines Revenue Forecast by Type (2022-2027)
15.3.3 Global Anti-Infective Vaccines Price Forecast by Type (2022-2027)
15.4 Global Anti-Infective Vaccines Consumption Volume Forecast by Application (2022-2027)
15.5 Anti-Infective Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
